Skip to main content

and
  1. Article

    Open Access

    AWARE A novel web application to rapidly assess cardiovascular risk in type 2 diabetes mellitus

    To describe the development of the AWARE App, a novel web application for the rapid assessment of cardiovascular risk in Type 2 Diabetes Mellitus (T2DM) patients. We also tested the feasibility of using this A...

    Cesare Berra, Roberto Manfrini, Marco Mirani, Loredana Bucciarelli in Acta Diabetologica (2023)

  2. Article

    Open Access

    Switching Patients with Type 1 Diabetes to Insulin Degludec from Other Basal Insulins: Real-World Data of Effectiveness and Safety

    Real-world evidence on the effectiveness and safety of insulin degludec (IDeg) in patients with diabetes is a priority. We have therefore evaluated the effectiveness and safety of IDeg, including impact on met...

    Paola Ponzani, Cesare Berra, Alessandra Di Lelio, Paola Del Sindaco in Diabetes Therapy (2020)

  3. No Access

    Article

    Hypoglycemia and hyperglycemia are risk factors for falls in the hospital population

    To determine the role of hypoglycemia, hyperglycemia or the combination of both as independent risk factors for falls in a hospital population. Secondary objectives included evaluation of other risk factors fo...

    Cesare Berra, Francesco De Fazio, Elena Azzolini, Marco Albini in Acta Diabetologica (2019)

  4. Article

    Open Access

    Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety

    Real-world evidence on effectiveness and safety of insulin degludec (IDeg) in patients with diabetes is a priority. The aim of the study was to evaluate patterns of use and the long-term effectiveness and safe...

    Paola Ponzani, Cesare Berra, Alessandra Di Lelio, Paola Del Sindaco in Diabetes Therapy (2018)

  5. Article

    Open Access

    Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in a Real-Life Setting: A 24-Month, Multicenter, Non-interventional, Retrospective Study

    The aim of the study was to evaluate whether the reduction in glycated hemoglobin (HbA1c) observed in clinical trials with liraglutide in type 2 diabetes (T2D) could be attained in routine clinical practice.

    Annunziata Lapolla, Cesare Berra, Massimo Boemi, Antonio Carlo Bossi in Advances in Therapy (2018)

  6. No Access

    Article

    Human proinsulin production in primary rat hepatocytes after retroviral vector gene transfer

    The development of autologous somatic cells, engineered for the synthesis and release of human insulin under physiological stimuli, would certainly represent a major breakthrough in the therapy of insulin-depe...

    L. Falqui, Sabina Martinenghi, Cesare Berra, Lucilla Monti in Journal of Molecular Medicine (1999)